Skip to main content
Premium Trial:

Request an Annual Quote

Pierce Inks Deal with GenTel to Distribute Slides, Use Tech for Protein Arrays

NEW YORK, Oct. 27 (GenomeWeb News) - Pierce Biotechnology, a unit of Fisher Biosciences, will distribute GenTel BioSurfaces's thin-film nitrocellulose slides and has also licensed GenTel technology to develop its onw protein arrays, the companies said yesterday.


GenTel's PATH brand slides are specifically designed for protein-array applications and are 50 times thinner than conventional nitrocellulose slides, GenTel said. The slides are also compatible with Pierce chemiluminescent-detection systems.


Pierce will use GenTel's technology to build on its SearchLight multiplex protein-profiling system. Microarray systems using GenTel's technology will allow researchers to measure the expression of up to 25 proteins in one experiment, the company said.


Additional details were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.